Literature DB >> 23052942

Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan.

J J Keller1, J-H Kang, H-C Lin.   

Abstract

UNLABELLED: This population-based analysis explored the association between osteoporosis and a previous diagnosis of psoriasis. We found that the adjusted odds ratio (OR) of having been previously diagnosed with psoriasis for subjects with osteoporosis was 1.65 (95 % confidence interval [CI], 1.42-1.94) when compared to controls.
INTRODUCTION: Although previous studies have investigated this association between psoriasis and osteoporosis, significant controversy remains regarding its presence. Therefore, this study set out to explore the association between osteoporosis and a previous diagnosis of psoriasis through a population-based case-control study in Taiwan.
METHODS: We identified 17,507 cases with a diagnosis of osteoporosis and randomly extracted 52,521 controls without a history of osteoporosis. We used conditional logistic regression analyses to calculate the OR for having been previously diagnosed with psoriasis.
RESULTS: Subjects with osteoporosis had a significantly higher prevalence of previously diagnosed psoriasis (1.50 % vs. 0.87 %, p < 0.001) compared to controls. Conditional logistic regression analysis revealed that the OR of having been previously diagnosed with psoriasis for subjects with osteoporosis was 1.65 (95 % CI, 1.42-1.94) when compared to controls after adjusting for monthly income, hypertension, diabetes, coronary heart disease, hyperlipidemia, rheumatoid arthritis, stroke, renal disease, Parkinson's disease, hyperthyroidism, chronic hepatopathy, Cushing's syndrome, malabsorption, tobacco use disorder, obesity, alcohol abuse/alcohol dependence syndrome, the use of SSRIs, and the use of systemic glucocorticoids. Furthermore, osteoporosis was significantly associated with a previous diagnosis of psoriasis in both sexes; the adjusted OR of prior psoriasis for cases when compared to controls was 1.52 (95 % CI, 1.16-1.99) and 1.73 (95 % CI, 1.44-2.13) for males and females, respectively. We also found that the adjusted OR of prior severe psoriasis for cases was 1.96 (95 % CI, 1.37-2.81) that of controls.
CONCLUSIONS: This investigation succeeded in detecting an association between osteoporosis and prior psoriasis among both men and women.

Entities:  

Mesh:

Year:  2012        PMID: 23052942     DOI: 10.1007/s00198-012-2185-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  29 in total

Review 1.  Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.

Authors:  M Wakkee; H B Thio; E P Prens; E J G Sijbrands; H A M Neumann
Journal:  Atherosclerosis       Date:  2006-08-30       Impact factor: 5.162

Review 2.  Osteoporosis and its management.

Authors:  Kenneth E S Poole; Juliet E Compston
Journal:  BMJ       Date:  2006-12-16

Review 3.  Clinical practice. Osteoporosis in men.

Authors:  Peter R Ebeling
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

4.  Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis.

Authors:  L C Hofbauer; M Schoppet; M Christ; J Teichmann; U Lange
Journal:  Rheumatology (Oxford)       Date:  2006-03-30       Impact factor: 7.580

5.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  A Tenenhouse; L Joseph; N Kreiger; S Poliquin; T M Murray; L Blondeau; C Berger; D A Hanley; J C Prior
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

6.  Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.

Authors:  Darko Kastelan; Marija Kastelan; Lara Prpic Massari; Mirko Korsic
Journal:  Med Hypotheses       Date:  2006-07-17       Impact factor: 1.538

7.  Bone mineral density and bone turnover in patients with psoriatic arthritis.

Authors:  Pinar Borman; Seçil Babaoğlu; Guneş Gur; Sezin Bingol; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

Review 8.  Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome.

Authors:  Gustavo Duque; Bruce R Troen
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

9.  Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy.

Authors:  Amra Osmancevic; Kerstin Landin-Wilhelmsen; Olle Larkö; Dan Mellström; Ann-Marie Wennberg; Lena Hulthén; Anne-Lene Krogstad
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

Review 10.  Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.

Authors:  W Sterry; B E Strober; A Menter
Journal:  Br J Dermatol       Date:  2007-07-11       Impact factor: 9.302

View more
  16 in total

Review 1.  Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.

Authors:  Rainer H Straub; Maurizio Cutolo; Roberto Pacifici
Journal:  Semin Arthritis Rheum       Date:  2015-04-30       Impact factor: 5.532

2.  The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Authors:  Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2017-01-16       Impact factor: 19.103

Review 3.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

Review 4.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 5.  Biologic therapies and bone loss in rheumatoid arthritis.

Authors:  C A F Zerbini; P Clark; L Mendez-Sanchez; R M R Pereira; O D Messina; C R Uña; J D Adachi; W F Lems; C Cooper; N E Lane
Journal:  Osteoporos Int       Date:  2016-10-31       Impact factor: 4.507

6.  Herpes zoster and the risks of osteoporosis and fracture: a nationwide cohort study.

Authors:  Shu-Man Lin; Chih-Yung Wang; Ying-Yu Chen; Jen-Hung Wang; Chung-Chao Liang; Huei-Kai Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-20       Impact factor: 5.103

Review 7.  Psoriasis: new comorbidities.

Authors:  Jackson Machado-Pinto; Michelle dos Santos Diniz; Nádia Couto Bavoso
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

8.  Increased Risk of Osteoporosis in Patients With Peptic Ulcer Disease: A Nationwide Population-Based Study.

Authors:  Chieh-Hsin Wu; Yi-Ching Tung; Chee-Yin Chai; Ying-Yi Lu; Yu-Feng Su; Tai-Hsin Tsai; Keng-Liang Kuo; Chih-Lung Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

9.  Bone mineral density is lower in male than female patients with plaque-type psoriasis in Iran.

Authors:  V Lajevardi; R Abedini; M Moghaddasi; S F Nassiri; A Goodarzi
Journal:  Int J Womens Dermatol       Date:  2017-09-20

10.  Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study.

Authors:  Chieh-Hsin Wu; Chee-Yin Chai; Yi-Ching Tung; Ying-Yi Lu; Yu-Feng Su; Tai-Hsin Tsai; Rong-Dar Tzou; Chih-Lung Lin
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.